BPharm, MSc, PhD
Honorary Research Fellow
- About
-
Biography
Eyob is an Honorary Research Fellow at the School of Medicine, Medical Sciences and Nutrition, the University of Aberdeen. He earned his Ph.D. from the University of Western Australia (Australia). He also holds a Bachelor's degree in pharmacy (BPharm.) and a Masters of Science (MSc.) degree in Clinical Pharmacy from the University of Gondar (Ethiopia).
Eyob is situated at the Quality Use of Medicine Research Centre (QUMPRC) at the University of South Australia (Australia), where he holds the position of a research fellow. He has extensive experience in research. Previously, he served as a lecturer in Clinical Pharmacy and a researcher at the University of Gondar. He also holds an Honorary Research Fellow position at the University of Western Australia (Australia).
As an Honorary Research Fellow at the University of Aberdeen, Eyob is currently investigating determinants of anticholinergic burden and outcomes in a Specialized Teaching Hospital in Ethiopia.
Qualifications
- Doctor of Philosophy (PhD) Pharmacy2023 - The University of Western Australia
- Masters of Science (MSc) Clinial Pharmacy2017 - University of Gondar
- Bachelor of Sciences (BSc) Pharmacy2014 - University of Gondar
- Higher Diploma Program Teaching Methods2018 - University of Gondar
Memberships and Affiliations
- Internal Memberships
-
Honorary Research Fellow at the School of Medicine, Medical Sciences and Nutrition, the University of Aberdeen
- External Memberships
-
External affiliations
- Research Fellow, Quality Use of Medicine Research Centre (QUMPRC), University of South Australia, Adelaide, SA, Australia
- Honorary Research Fellow and lecturer at the School of Allied Health, the University of Western Australia, Perth, WA, Australia
External memberships
- Academic Editor - PLOS ONE
- International Pharmaceutical Federation (FIP): The Hague, NL (2022 to Present)
- Australian-Based Ethiopian Researchers Network (ABReN): Canberra, ACT, AU (2020 to Present)
- International Society for Pharmacoeconomics and Outcomes Research (ISPOR): Lawrenceville, NJ, US (2017 to Present)
- International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Ethiopia Regional Chapter: Gondar, Amhara, ET (2017 to Present)
- Ethiopian Pharmaceutical Association (EPA): Addis Ababa, ET (2016 to Present)
- Global Burden of Diseases Collaborator Network – University of Washington, Seattle, WA, USA (2020 to Present)
- Amhara National Regional State Health Bureau, member of the regional drug-resistant tuberculosis (DR TB) Clinical Review Committee (CRC), Bahirdar, ET (2018-2019)
- International Pharmacy Students Federation (IPSF): Amsterdam, NL (2016 to 2018)
- Young African Leaders Initiative (YALI) Network, USA (2015 to Present)
Latest Publications
Anticholinergic burden and health-related quality of life among adult patients in a resource-limited setting: a cross-sectional study
International Journal of Clinical Pharmacy, vol. 46, no. 6, pp. 1352-1361Contributions to Journals: ArticlesAnticholinergic burden among in-patients: a cross-sectional study on prevalence, determinants, and impact on mortality in Ethiopia
Therapeutic Advances in Drug Safety, vol. 15, pp. 1-12Contributions to Journals: ArticlesGlobal, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
The Lancet Gastroenterology & Hepatology, vol. 7, no. 9, pp. 796-829Contributions to Journals: ArticlesRisk of Gastrointestinal Bleeding on Treatment With Statin Alone or With Concomitant Administration of Warfarin:: A Systematic Review and Meta-analysis of 5.3 Million Participants
The Annals of Pharmacotherapy, vol. 56, no. 7, pp. 820 - 830Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1177/10600280211049727
Use of thromboprophylaxis guidelines and risk stratification tools in atrial fibrillation: A survey of general practitioners in Australia
Journal of Evaluation in Clinical Practice, vol. 28, no. 3, pp. 483-492Contributions to Journals: Articles
- Research
-
Funding and Grants
The University of Western Australia Graduate Research School (GRS) conference travel grant worth A$1,850 (May 2022)
The University of Western Australia International Fee Scholarship (UIFS) worth A$182,000 (May 2019)
The University of Western Australia University Postgraduate Award (UPA) worth A$90,000 (May 2019)
International Student Congress of Medical Sciences (ISCOMS) Research Fellowship held in University Medical Center Groningen (UMCG) in Groningen, the Netherlands, from June 8-20, 2019, organized by ISCOMS (April 2019)
International Student Congress of Medical Sciences (ISCOMS) conference travel grant for attending the 26th ISCOMS held in University Medical Center Groningen in Groningen, the Netherlands worth €200 (April 2019)
University of Gondar Community Service Grant for Capacity building of community pharmacy pharmacists as primary healthcare workers and partnering with them in prevention and control of chronic diseases and childhood illness worth ~US$1,100 (November 2018)
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) conference travel grant for attending the 20th ISPOR Annual European Congress held in Glasgow, the United Kingdom worth US$2,500 (April 2017)
International Network for Advancing Science and Policy (INASP) AuthorAid conference travel grant for attending the 6th International Pharmaceutical Federation (FIP) Pharmaceutical Sciences World Congress (PSWC) held in Stockholm, Sweden worth US$1,500 (March 2017)
University of Gondar Community Service Grant for Strengthening Clinical Pharmacy Services in Selected Hospitals of Amhara Region worth ~US$24,000 (January 2016)
- Publications
-
Page 5 of 5 Results 41 to 42 of 42
Recreational Use of Phosphodiesterase 5 Inhibitors and Its Associated Factors among Undergraduate Male Students in an Ethiopian University: A Cross-Sectional Study
The World Journal of Men's Health, vol. 34, no. 3, pp. 186-193Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.5534/wjmh.2016.34.3.186
Patients with HFpEF and HFrEF have different clinical characteristics but similar prognosis: a retrospective cohort study
BMC Cardiovascular Disorders, vol. 16, no. 1, 232Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1186/s12872-016-0418-9